
Retatrutide
Price | Get Latest Price | |
Package | 15mg | 30mg |
Min. Order: | 15mg |
Supply Ability: | 5000box |
Update Time: | 2025-03-12 |
Product Details
Product Name: Retatrutide | CAS No.: 2381089-83-2 |
Min. Order: 15mg | Purity: 99% |
Supply Ability: 5000box | Release date: 2025/03/12 |
?Retatrutide (LY3437943) | GIP/GLP-1/GCGR Triple Agonist Peptide?
?? ?Product Overview?
Retatrutide is a novel ?triple agonist peptide? targeting GIP, GLP-1, and GCGR receptors, designed to regulate glucose metabolism and promote weight loss. It combines the therapeutic benefits of incretin hormones and glucagon activity, making it a breakthrough in metabolic disorder treatment. Primary applications include ?obesity management? and ?type 2 diabetes therapy? with enhanced efficacy compared to single-target agents?15.
?? ?Key Advantages?
? ?Triple-Action Mechanism?: Simultaneously activates GIP, GLP-1, and GCGR receptors for synergistic metabolic effects.
? ?High Efficacy?: Clinical trials show ?≥15% weight reduction? in obese patients and ?HbA1c reduction by 1.5-2.0%? in diabetics?15.
? ?Extended Half-Life?: Engineered peptide structure ensures prolonged activity with once-weekly dosing.
?? ?Application Areas?
?Obesity Treatment?: Reduces appetite and enhances energy expenditure.
?Type 2 Diabetes?: Improves glycemic control and insulin sensitivity.
?Cardiometabolic Health?: Potential benefits in NAFLD (non-alcoholic fatty liver disease) and cardiovascular risk reduction?.
?? ?Quality & Compliance?
?HPLC purity ≥98%?.
Compliant with ?USP/EP standards? for peptide synthesis and stability testing.
?? ?Market Trends?
The global ?anti-obesity drug market? is projected to reach ?$54.8 billion by 2030? (CAGR 14.2%), driven by rising obesity rates and demand for multi-target therapies. Retatrutide’s triple-action profile positions it as a leader in next-generation metabolic treatments?5.
Company Profile Introduction
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$27.00/1Box |
VIP1Y
|
American HealthyMorph LLC
|
2025-03-10 | |
$5.00/1mg |
VIP1Y
|
Hebei Mujin Biotechnology Co.,Ltd
|
2025-03-07 | |
$0.00/25KG |
VIP5Y
|
Hebei Mujin Biotechnology Co.,Ltd
|
2025-03-06 | |
$20.00/1g |
VIP3Y
|
GIHI CHEMICALS CO.,LIMITED
|
2025-02-12 | |
$0.00/1g |
VIP1Y
|
Wuhan Circle Star Chem-medical Technology Co.,Ltd
|
2025-01-22 | |
$5.00/1box |
VIP1Y
|
Hebei Jiafan Trading Company Limited
|
2025-01-08 | |
$130.00/10BOX |
VIP1Y
|
Hebei Shengyang Water Conservancy Engineering Co., Ltd.
|
2025-01-06 | |
$0.00/1g |
VIP1Y
|
Zhangzhou Sinobioway Peptide Co.,Ltd.
|
2024-12-17 | |
$20.00/1kg |
Shaanxi Franta Biotechnology Co., Ltd
|
2024-12-06 | ||
$60.00/1Box |
Hebei Weimiao Import and Export Trade Co., Ltd.
|
2024-11-12 |
- Since: 2018-06-08
- Address: Biolake.858 high-tech avenue,Wuhan
+86-+undefined-+86 13343427080
sales@biocarchem.com